Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Net Cash Flow (2016 - 2026)

Champions Oncology (CSBR) has 16 years of Net Cash Flow data on record, last reported at -$1.8 million in Q4 2025.

  • For Q4 2025, Net Cash Flow fell 1210.87% year-over-year to -$1.8 million; the TTM value through Oct 2025 reached $5.8 million, up 308.84%, while the annual FY2025 figure was $7.2 million, 195.56% up from the prior year.
  • Net Cash Flow reached -$1.8 million in Q4 2025 per CSBR's latest filing, down from $540000.0 in the prior quarter.
  • Across five years, Net Cash Flow topped out at $6.6 million in Q2 2025 and bottomed at -$5.2 million in Q3 2023.
  • Average Net Cash Flow over 5 years is -$1850.0, with a median of $68000.0 recorded in 2024.
  • The widest YoY moves for Net Cash Flow: up 455.84% in 2025, down 1210.87% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at $783000.0 in 2021, then soared by 253.51% to $2.8 million in 2022, then crashed by 76.73% to $644000.0 in 2023, then plummeted by 121.43% to -$138000.0 in 2024, then plummeted by 1210.87% to -$1.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Cash Flow were -$1.8 million in Q4 2025, $540000.0 in Q3 2025, and $6.6 million in Q2 2025.